Xenon Pharmaceuticals Inc. (XENE): EPS (Diluted)
-$4.36
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$4.36 | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$3.01 | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$2.73 | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$2.06 | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$1.77 | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$0.81 | n/a | 2023-03-01, From 2020-01-01 |
| No annual figure between 2018-12-31 and 2020-12-31. | |||
| 2018-12-31 | -$1.63 | n/m | 2019-03-06, From 2018-01-01 |
| 2017-12-31 | -$1.72 | n/m | 2019-03-06, From 2017-01-01 |
| 2016-12-31 | -$1.48 | n/m | 2018-03-07, From 2016-01-01 |
| 2015-12-31 | -$1.10 | n/m | 2018-03-07, From 2015-01-01 |
| 2014-12-31 | $3.28 | +71.7% | 2017-03-08, From 2014-01-01 |
| 2013-12-31 | $1.91 | n/m | 2016-03-08, From 2013-01-01 |
| 2012-12-31 | -$3.24 | n/a | 2015-03-12, From 2012-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | 2025-12-31 | -$4.36 | n/m |
| Adagene Inc. (ADAG) | 2025-12-31 | -$0.30 | n/m |
| Bolt Biotherapeutics, Inc. (BOLT) | 2025-12-31 | -$17.85 | n/m |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | -$0.53 | n/m |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | -$0.33 | n/m |
| Coya Therapeutics, Inc. (COYA) | 2025-12-31 | -$1.27 | n/m |
| Immunome Inc. (IMNM) | 2025-12-31 | -$2.43 | n/m |
| Roivant Sciences Ltd. (ROIV) | 2026-03-31 | -$0.54 | n/m |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | -$12.48 | n/m |
Compare XENE, ADAG, BOLT, ACRS side by side · Screen every company in Pharmaceutical Preparations ↗